» Articles » PMID: 27571009

Genome-wide, Integrative Analysis Implicates MicroRNA Dysregulation in Autism Spectrum Disorder

Overview
Journal Nat Neurosci
Date 2016 Aug 30
PMID 27571009
Citations 108
Authors
Affiliations
Soon will be listed here.
Abstract

Genetic variants conferring risk for autism spectrum disorder (ASD) have been identified, but the role of post-transcriptional mechanisms in ASD is not well understood. We performed genome-wide microRNA (miRNA) expression profiling in post-mortem brains from individuals with ASD and controls and identified miRNAs and co-regulated modules that were perturbed in ASD. Putative targets of these ASD-affected miRNAs were enriched for genes that have been implicated in ASD risk. We confirmed regulatory relationships between several miRNAs and their putative target mRNAs in primary human neural progenitors. These include hsa-miR-21-3p, a miRNA of unknown CNS function that is upregulated in ASD and that targets neuronal genes downregulated in ASD, and hsa_can_1002-m, a previously unknown, primate-specific miRNA that is downregulated in ASD and that regulates the epidermal growth factor receptor and fibroblast growth factor receptor signaling pathways involved in neural development and immune function. Our findings support a role for miRNA dysregulation in ASD pathophysiology and provide a rich data set and framework for future analyses of miRNAs in neuropsychiatric diseases.

Citing Articles

MicroRNA Profiling Identifies Age-Associated MicroRNAs and Potential Biomarkers for Early Diagnosis of Autism.

Salloum-Asfar S, Ltaief S, Taha R, Nour-Eldine W, Abdulla S, Al-Shammari A Int J Mol Sci. 2025; 26(5).

PMID: 40076668 PMC: 11900285. DOI: 10.3390/ijms26052044.


Glycosylation Pathways Targeted by Deregulated miRNAs in Autism Spectrum Disorder.

Mirabella F, Randazzo M, Rinaldi A, Pettinato F, Rizzo R, Sturiale L Int J Mol Sci. 2025; 26(2).

PMID: 39859496 PMC: 11766332. DOI: 10.3390/ijms26020783.


Transcriptomic Evidence Reveals the Dysfunctional Mechanism of Synaptic Plasticity Control in ASD.

Kong C, Bing Z, Yang L, Huang Z, Wang W, Grebogi C Genes (Basel). 2025; 16(1).

PMID: 39858558 PMC: 11764921. DOI: 10.3390/genes16010011.


MicroRNAs as Regulators, Biomarkers, and Therapeutic Targets in Autism Spectrum Disorder.

Yao T, Chen L, Du Y, Jiang Z, Cheng Y Mol Neurobiol. 2024; 62(4):5039-5056.

PMID: 39503812 DOI: 10.1007/s12035-024-04582-x.


Autism spectrum disorder: difficulties in diagnosis and microRNA biomarkers.

Martinez B, Peplow P Neural Regen Res. 2024; 20(10):2776-2786.

PMID: 39314171 PMC: 11826456. DOI: 10.4103/NRR.NRR-D-24-00712.


References
1.
Arbiza L, Gronau I, Aksoy B, Hubisz M, Gulko B, Keinan A . Genome-wide inference of natural selection on human transcription factor binding sites. Nat Genet. 2013; 45(7):723-9. PMC: 3932982. DOI: 10.1038/ng.2658. View

2.
Anders S, Pyl P, Huber W . HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics. 2014; 31(2):166-9. PMC: 4287950. DOI: 10.1093/bioinformatics/btu638. View

3.
Mor M, Nardone S, Sams D, Elliott E . Hypomethylation of miR-142 promoter and upregulation of microRNAs that target the oxytocin receptor gene in the autism prefrontal cortex. Mol Autism. 2015; 6:46. PMC: 4535255. DOI: 10.1186/s13229-015-0040-1. View

4.
Kang H, Kawasawa Y, Cheng F, Zhu Y, Xu X, Li M . Spatio-temporal transcriptome of the human brain. Nature. 2011; 478(7370):483-9. PMC: 3566780. DOI: 10.1038/nature10523. View

5.
Geschwind D, State M . Gene hunting in autism spectrum disorder: on the path to precision medicine. Lancet Neurol. 2015; 14(11):1109-20. PMC: 4694565. DOI: 10.1016/S1474-4422(15)00044-7. View